The problem of hypoperfusion despite recanalization: A systematic review and meta-analysis of randomized clinical trials of intra-arterial thrombolysis as an adjunct to successful recanalization

Abstract BACKGROUND: The efficacy of intra-arterial (IA) thrombolysis following successful endovascular thrombectomy (EVT) in acute ischemic stroke remains controversial, with conflicting evidence. METHODS: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, ClinicalTrials.gov, and International Stroke Conference proceedings through July 18, 2025, for randomized controlled trials (RCTs) comparing IA thrombolysis versus placebo/no treatment after successful EVT. Statistical pooling with random effects was undertaken to calculate risk ratios of functional outcome (modified Rankin Scale [mRS]) at 90 days, changes in National Institutes of Health Stroke Scale score, health-related quality of life measured with the European Quality of Life 5-Dimension 5-Level scores, and safety measures. Additional subgroup analyses were performed according to key clinical and treatment characteristics. RESULTS: Six RCTs involving 1,923 patients (979 receiving IA thrombolysis, 944 controls) were included. IA thrombolysis was associated with higher rates of excellent functional outcome (risk ratio [RR] 1.24, 95% confidence interval [CI] 1. 10–1.39, P = 0.0001, I² = 15%). Subgroup analysis revealed significant benefit in patients with eTICI 2b (RR: 1.51, 95% CI: 1.02–2.24) but not eTICI 2c/3 (RR: 1.22, 95% CI: 0.99–1.50). While functional independence (mRS 0–2) showed no significant difference (RR: 1.05, 95% CI: 0.97–1 .14 ), the ordinal analysis demonstrated a favorable mRS shift (common odds ratio: 1.22, 95% CI: 1.04–1.43). No significant differences were observed in mortality at 90 days, or symptomatic intracerebral hemorrhage. CONCLUSIONS: IA thrombolysis following successful EVT recanalization may improve excellent functional outcomes at 90 days, particularly in patients with eTICI 2b reperfusion, without raising safety concerns.

Authors

Institutions

Publication Details

Journal
Brain Circulation
Published
2025-10-15
DOI
https://doi.org/10.4103/bc.bc_101_25
Citations
1
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
1.35
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The problem of hypoperfusion despite recanalization: A systematic review and meta-analysis of randomized clinical trials of intra-arterial thrombolysis as an adjunct to successful recanalization

Jean‐Claude Baron, Wenbo Zhao, Adrien ter Schiphorst, Yi Xu et al.
1 citations
Brain Circulation
Acute Ischemic Stroke Management
1.35
article

The problem of hypoperfusion despite recanalization: A systematic review and meta-analysis of randomized clinical trials of intra-arterial thrombolysis as an adjunct to successful recanalization

Jean‐Claude Baron, Wenbo Zhao, Adrien ter Schiphorst, Yi Xu, Hui Wen, Xunming Ji, Yue Qiao
article en
1 citations

Abstract

Abstract BACKGROUND: The efficacy of intra-arterial (IA) thrombolysis following successful endovascular thrombectomy (EVT) in acute ischemic stroke remains controversial, with conflicting evidence. METHODS: We systematically searched PubMed, Embase, Cochrane Library, Web of Science, ClinicalTrials.gov, and International Stroke Conference proceedings through July 18, 2025, for randomized controlled trials (RCTs) comparing IA thrombolysis versus placebo/no treatment after successful EVT. Statistical pooling with random effects was undertaken to calculate risk ratios of functional outcome (modified Rankin Scale [mRS]) at 90 days, changes in National Institutes of Health Stroke Scale score, health-related quality of life measured with the European Quality of Life 5-Dimension 5-Level scores, and safety measures. Additional subgroup analyses were performed according to key clinical and treatment characteristics. RESULTS: Six RCTs involving 1,923 patients (979 receiving IA thrombolysis, 944 controls) were included. IA thrombolysis was associated with higher rates of excellent functional outcome (risk ratio [RR] 1.24, 95% confidence interval [CI] 1. 10–1.39, P = 0.0001, I² = 15%). Subgroup analysis revealed significant benefit in patients with eTICI 2b (RR: 1.51, 95% CI: 1.02–2.24) but not eTICI 2c/3 (RR: 1.22, 95% CI: 0.99–1.50). While functional independence (mRS 0–2) showed no significant difference (RR: 1.05, 95% CI: 0.97–1 .14 ), the ordinal analysis demonstrated a favorable mRS shift (common odds ratio: 1.22, 95% CI: 1.04–1.43). No significant differences were observed in mortality at 90 days, or symptomatic intracerebral hemorrhage. CONCLUSIONS: IA thrombolysis following successful EVT recanalization may improve excellent functional outcomes at 90 days, particularly in patients with eTICI 2b reperfusion, without raising safety concerns.

Brain Circulation
Inserm (FR), Capital Medical University (CN), Université Paris Cité (FR), University of Cambridge (GB), Sichuan University (CN), West China Hospital of Sichuan University (CN), Hôpital Gui de Chauliac (FR), Chinese Institute for Brain Research (CN), Institut de Psychiatrie et Neurosciences de Paris (FR), FHU Neurovasc (FR)
Openalex Percentile: Top 15%
Acute Ischemic Stroke Management
1.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.